Search Legislation

The Plant Protection Products (Fees and Charges) (Amendment) Regulations 2016

 Help about what version

What Version

  • Latest available (Revised)
  • Original (As made)
 Help about opening options

Opening Options

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Amendment of the Plant Protection Products (Fees and Charges) Regulations 2011

This section has no associated Explanatory Memorandum

2.—(1) The Plant Protection Products (Fees and Charges) Regulations 2011(1) are amended as follows.

(2) For Schedule 1, substitute—

Regulation 4(1)

SCHEDULE 1Fees

Fees for application and evaluation of a plant protection product for authorisation

1.  Fees for product-related applications are in accordance with the following table, and each item is charged cumulatively.

ItemChargeable itemFee(£)
1Administrative research and development application(1)52
2Extension of use application including administration, co-ordination and technical consideration1,768
3Preliminary consideration of application type listed in items 4, 5, 7,12 or 13 to determine whether the application can proceed further229
4Administrative application(2)(3) for a new product or change to an existing product—
4aone product156
4beach additional product(4)52
5Parallel trade applications—
5aco-ordination of application for a new product or change to an existing product involving parallel trade(5)728
5bparallel trade verification(6)208
6Evaluation of a label in any application208
7Co-ordination of standard technical stream applications (7) (8)1,872
8Evaluation of simple reasoned cases in each of the following specialist areas—
8achemistry(9)416
8btoxicology(10)416
8coperator exposure(11)416
8dresidues and consumer exposure(12)416
8efate and behaviour in the environment(13)416
8fecotoxicology(14)416
8gefficacy(15)416
9Evaluation of data, modelling and detailed scientific cases in each of the following specialist areas—
9achemistry(9)780
9btoxicology(10)780
9coperator exposure(11)780
9dresidues and consumer exposure(12)780
9efate and behaviour in the environment(13)1,872
9fecotoxicology(14)1,872
9gefficacy(15)1,872
10Withdrawal of an application for a product specified in items 2, 4, 5, 7, 12 or 13 before any work other than preliminary consideration has been done104
11Pre-submission meetings for lead zonal re-registration and new product applications(16)5,200
12Zonal surcharge for lead zonal re-registration and new product applications. This fee is in addition to those described in 7 to 9 above (17)
Zonal surcharge 17,800
Zonal surcharge 215,600
13Commenting on draft study protocols(18)416

Notes

(1) Application for authorisation under Regulation 1107/2009 not involving evaluation of technical information or data.

(2) Application for authorisation under Regulation 1107/2009 involving no technical consideration.

(3) Application for a parallel trade permit for personal use only.

(4) Where the application relates to a number of different products, this charge applies to each additional product.

(5) Application for a parallel trade permit for other than personal use.

(6) Verification that the product to be traded is identical to a product authorised in the part of the United Kingdom to which the application relates in accordance with Regulation 1107/2009.

(7) “Standard technical stream applications” are all applications other than items 1-5, 10, 11 and 12.

(8) The co-ordination of applications for new products or a change to an existing product.

(9) Chemistry covers assessment of the technical specification of the active substance, safeners and synergists in the product and the physico-chemical properties of the product.

(10) Toxicology covers assessment of the mammalian metabolism and toxicology of the active substance, safeners and synergists in the product and determination of the types of hazard to which the product can give rise.

(11) Operator exposure additionally covers exposure of other persons resulting from the product use.

(12) Consumer exposure covers exposure of consumers resulting from consumption of produce from treated crops, treated produce or products derived from either, including products from animals to which any such matter has been fed.

(13) Fate and behaviour in the environment covers the potential environmental exposure from product use, including the identity and quantity of the active substance, metabolites, degradation products and reaction products, safeners and synergists which may be available in the soil, water or air and are of toxicological or environmental significance.

(14) Ecotoxicology covers the assessment of the potential impact on non-target species likely to be at risk from exposure to the product, including the active substance, and toxicologically or environmentally significant metabolites, degradation products and reaction products, safeners and synergists.

(15) Efficacy covers the assessment of whether a product consistently controls the target pest and whether the product adversely affects the treated crops, following crops or treated produce.

(16) Pre-submission meetings may be held at the request of the applicant prior to the submission of an application to the United Kingdom to act as lead zonal rapporteur.

(17) A Zonal surcharge is applied to any new product or re-registration application for which the United Kingdom has been requested to act as the Central Zone lead Member State. This fee covers the additional co-ordination and evaluation work required to support approvals in other Member States over and above what is required in the United Kingdom. Zonal surcharge 1 is the minimum additional fee applied. Zonal Surcharge 2 is applied for any use or uses required in another Member State but not in the United Kingdom. For particularly complex protocols requiring significant specialist input it may be necessary to charge a data module fee in the relevant specialist area.

(18) The fee is equivalent to a specialist case fee and relates to requests from applicants for the United Kingdom to comment on the study design in advance of the data being generated and an application being submitted. For particularly complex protocols requiring significant specialist input it may be necessary to charge a data module fee in the relevant specialist area.

Fees for application and evaluation of an active substance, safener or synergist

2.  The fees for evaluation for approval, or renewal of approval, under Regulation 1107/2009 of an active substance, safener or synergist, are in accordance with the following table.

ItemApplicationFee(£)
Where an active substance, safener or synergist is neither a biocontrol agent nor a pheromone
1Preliminary evaluation(1) of the admissibility of an application5,200
2Processing an application for provisional authorisation (2)36,400
3Helping the European Food Safety Authority to evaluate the draft assessment report where the United Kingdom is the rapporteur or co-rapporteur Member State in relation to an application for approval36,400
4Evaluation of a full data package(3)114,400
5Evaluation of a partial data package(4):
Band 17,800
Band 215,600
Band 331,200
Band 452,000
Band 572,800
Band 693,600
Band 7114,400
Where an active substance is a biocontrol agent
6Evaluation of a full data package (3)23,400
7Helping the European Food Safety Authority to evaluate the draft assessment report where the United Kingdom is the rapporteur or co-rapporteur Member State in relation to an application for approval7,800
8Evaluation of a partial data package(4):
Band 15,720
Band 211,700
Band 317,680
Band 423,400
Where an active substance is a pheromone
9Evaluation of a full data package(3)13,520
10Helping the European Food Safety Authority to evaluate the draft assessment report where the United Kingdom is the rapporteur or co-rapporteur Member State in relation to an application for an approval7,800
11Evaluation of a partial data package:(4)
Band 13,380
Band 26,760
Band 310,140
Band 413,520
For all evaluations
12Meeting before the submission of an application in support of a new active substance, safener, synergist, biocontrol agent or pheromone5,200

Notes

(1) The initial evaluation carried out in order to notify the applicant whether his or her application can proceed further.

(2) Application in accordance with Article 30 of Regulation 1107/2009 for a provisional authorisation in the United Kingdom (not exceeding 3 years) for a plant protection product containing a new active substance for which a decision on approval has been delayed by more than 30 months from the date of admissibility of the original application.

(3) A full data package comprises the complete dossier (the information referred to in paragraphs 1 and 2 of Article 8 of Regulation 1107/2009) to support one or more representative use of one product. Where a data package also contains a large number of extra study reports submitted to refine risk assessments, to characterise metabolites or to support additional uses of the product, these studies will be treated as an additional partial data package. See also note (4).

(4) The size of a partial data package is banded as a proportion of a full data package. The proportion is estimated on the basis of the amount of time required to evaluate the data and to conduct the necessary risk assessments. Applicants will be notified of the appropriate Band prior to an evaluation taking place. Partial data packages include one or more of the following—

(a)additional data over and above a ‘standard’ core dossier for example situations where there are significantly more metabolites, or very large novel studies to be evaluated;

(b)additional study submissions during evaluation required to clarify the initial dossier;

(c)resubmissions where, for example, the previous application for approval or inclusion in Annex 1 to Directive 91/414/EEC(2) or for approval or renewal of approval under Regulation 1107/2009 has been unsuccessful and a new application is made in an attempt to address all the concerns raised from that earlier submission;

(d)data to support the extension of the approval of an active substance, safener or synergist under Regulation 1107/2009 once the initial approval period has expired or to change the conditions of approval during the approval period;

(e)data to support the evaluation of an active substance under Regulation 1107/2009 once the initial period of inclusion in Annex 1 of Directive 91/414/EEC has expired. The full dossier is not required just additional data to demonstrate compliance with any new guidance, regulations or scientific advances;

(f)large data packages in one or more areas of the risk assessment that have been submitted in support of product related applications (e.g. re-registration and new product applications under Regulation 1107/2009) that significantly exceed the size for which the standard fees specified in the product-related application fees table (paragraph 1, items 9a-g above) are payable.

(g)Additional studies submitted to support an adverse data review.

A joint evaluation where the United Kingdom and one or more other Member States share the evaluation of a dossier and evaluation of scientific peer reviewed open literature on the active substance and its relevant metabolites will be treated as partial data packages.

Fees for official recognition of a test facility or organisation

3.  The fees for the official recognition of a test facility or organisation are in accordance with the following table(1).

ItemActivityFee (£)
1Initial official recognition of the test facility2,080
2Renewal of an official recognition2,080
3Each re-inspection1,560

Notes

(1) Article 29(3) of Regulation 1107/2009 requires that compliance with certain authorisation requirements is established by official or officially recognised tests and analyses.

Fees related to application for approval of basic substances

4.  The fees for work involved in assisting an applicant in preparing or submitting an application for approval of a basic substance under Article 23 of Regulation 1107/2009 are in accordance with the following table.

ItemApplicationFee(£)
1Assistance with a full data package(1)114,400
2Assistance with a partial data package(2):
Band 17,800
Band 215,600
Band 331,200
Band 452,000
Band 572,800
Band 693,600
Band 7114,400

Notes

(1) A full data package comprises the complete dossier (the information referred to in Article 23(3) of Regulation 1107/2009) to support one or more uses of the basic substance. Where a data package also contains a large number of extra study reports submitted to refine risk assessments, to characterise metabolites or to support additional uses, these studies will be treated as an additional partial data package. See also note (2).

(2) The size of a partial data package is banded as a proportion of a full data package. The percentage is estimated on the basis of the amount of time required to evaluate the data and to conduct the necessary risk assessments. Applicants will be notified of the appropriate Band prior to an evaluation taking place. Partial data packages include one or more of the following —

(a)additional data over and above a ‘standard’ core dossier, for example, situations where there are significantly more metabolites, or very large novel studies to be evaluated;

(b)additional study submissions during evaluation required to clarify the initial dossier;

(c)resubmissions, for example, where the previous application for approval under Regulation 1107/2009 has been unsuccessful and a new application is made in an attempt to address all the concerns raised from that earlier submission;

(d)data to support a change to the conditions of approval of the basic substance;

(e)joint evaluation where the United Kingdom and one or more other Member States share the evaluation of the dossier.

The evaluation of scientific peer reviewed open literature on the basic substance and its relevant metabolites is treated as a partial data package.

(3) For Schedule 2 substitute—

Regulation 4(2)

SCHEDULE 2Import tolerance fee

Fees for product-related applications are in accordance with the following table.

ItemCategoryFee(£)
1Full Human health description(1)16,224
2Metabolism and residues evaluation(2)6,760
3Residues evaluation(3)2,028

Notes

(1) This category is mainly for plant protection products not currently authorised in any Member State. In certain cases, it may also include plant protection products still being reviewed if toxicological endpoints have not yet been agreed at a European level.

(2) This category is for plant protection products where toxicological endpoints have already been agreed at a European level, but the residue definition has only been established for crop groups unrelated to the intended use or imported produce.

(3) This category is for plant protection products where relevant toxicological endpoints and residue definition have already been agreed at European level.

(2)

OJ No. L230, 19.8.1991, p.1.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Impact Assessments

Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:

  • Why the government is proposing to intervene;
  • The main options the government is considering, and which one is preferred;
  • How and to what extent new policies may impact on them; and,
  • The estimated costs and benefits of proposed measures.
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources